Folic acid has been evaluated in numerous clinical trials and non-interventional studies spanning Phase 1 through Phase 4 evaluations across hematologic, neurological, and structural birth defect indications. Prominent institutional sponsors, including The University of Hong Kong, Queen's University, Beni-Suef University, Xuzhou Medical University, and the University of Iowa, have driven these investigations across completed, active, recruiting, and withdrawn protocols. Overall, these trials reflect sustained clinical interest in assessing folic acid supplementation for conditions ranging from deficiency anemias and pediatric vaso-occlusive crises to oral cleft prevention.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT07113158 | NOT_YET_RECRUITING | Sudden Sensorineural Hearing Loss |
Assistance Publique - Hôpitaux de Paris |
2026-04-01 | PHASE3 |
| NCT06641245 | NOT_YET_RECRUITING | Folate; Folate Bioavailability; Clinical Trials; Pregnancy |
University of British Columbia |
2025-01-31 | |
| NCT07241221 | RECRUITING | Perinatal and Neonatal Outcomes in Pregnancies With Type 2 Diabetes Mellitus (T2DM) |
National University Hospital, Singapore |
2025-12 | |
| NCT07695883 | NOT_YET_RECRUITING | Neurodevelopment Outcome; Linear Growth; Micronutrient Status; Bone Mineral Density; Underweight; Stunting; Body Composition; Blood Pressure; HRQOL (Health Related Quality Of Life); Waist-to-height Ratio |
Johns Hopkins Bloomberg School of Public Health |
2026-10-01 | PHASE3 |
| NCT07697196 | NOT_YET_RECRUITING | HPV Infection; HPV Integration; HPV Disease; HPV Genital Infection; HPV Persistence; Low Grade Squamous Intraepithelial Lesions of the Cervix |
IRCCS San Raffaele |
2026-07 | |
| NCT07680595 | RECRUITING | Carotid Atherosclerotic Plaque |
Ruijin Hospital |
2026-03-01 | PHASE1; PHASE2 |
| NCT07344337 | NOT_YET_RECRUITING | HPV Infection; Infertilities |
Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
2026-03 | |
| NCT05096663 | ACTIVE_NOT_RECRUITING | Advanced Lung Non-Small Cell Carcinoma; Recurrent Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8 |
SWOG Cancer Research Network |
2022-03-15 | PHASE2; PHASE3 |
| NCT06734611 | RECRUITING | Folate Deficiency; Neural Tube Defects |
University of Alabama at Birmingham |
2026-04-10 | |
| NCT07013136 | NOT_YET_RECRUITING | Acute Kidney Injury |
The University of Hong Kong |
2025-10-01 | EARLY_PHASE1 |
| NCT01687127 | NOT_YET_RECRUITING | One-carbon Metabolism in Healthy Individuals |
University of British Columbia |
2024-01-01 | |
| NCT07648251 | NOT_YET_RECRUITING | Severe Preeclampsia |
Universidad Nacional Autonoma de Honduras |
2026-06-15 | PHASE2 |
| NCT07665957 | NOT_YET_RECRUITING | Maternal Anemia; Micronutrient Deficiency; Pregnancy Outcomes; Maternal Nutrition |
Sindh Institute of Child Health and Neonatology |
2026-06-25 | |
| NCT04579848 | ACTIVE_NOT_RECRUITING | Hand Osteoarthritis; Erosive Osteoarthritis |
Diakonhjemmet Hospital |
2021-08-12 | PHASE4 |
| NCT07661602 | NOT_YET_RECRUITING | Anemia |
Southern Medical University, China |
2026-07 | PHASE3 |
| NCT05612984 | WITHDRAWN | Preterm Labor; Small for Gestational Age at Delivery; Hypertensive Disorder of Pregnancy; Low Birth Weight; Neonatal Death |
Johns Hopkins Bloomberg School of Public Health |
2024-04-01 | PHASE3 |
| NCT05284656 | ACTIVE_NOT_RECRUITING | Chronic Kidney Diseases |
Al-Azhar University |
2022-01-08 | PHASE3 |
| NCT06768294 | NOT_YET_RECRUITING | Calcium Pyrophosphate Deposition Disease; Chondrocalcinosis |
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio |
2025-01 | PHASE2 |
| NCT07540130 | ACTIVE_NOT_RECRUITING | Pregnant Women; Pregnant Women and Their Offspring |
National Institute of Neurosciences and Hospital, Dhaka |
2025-02-11 | PHASE1; PHASE2 |
| NCT04024254 | COMPLETED | Ovarian Cancer; Breast Cancer; Folic Acid Deficiency |
Rush University Medical Center |
2020-07-21 | PHASE4 |
| NCT07725549 | COMPLETED | Maternal Micronutrient Status; Pregnancy; Low Birth Weight; Maternal Anemia |
Indonesia Timur University |
2025-07-10 | |
| NCT07029698 | COMPLETED | Vitamin B12 Deficiency |
Medice Arzneimittel Pütter GmbH & Co KG |
2025-04-16 | PHASE4 |
| NCT04310059 | UNKNOWN | Thalassemia; Folic Acid Deficiency Anemia |
The University of Hong Kong |
2024-07-01 | |
| NCT06327646 | ACTIVE_NOT_RECRUITING | Supplementation |
Helen Keller International |
2024-07-04 | |
| NCT05378919 | RECRUITING | Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX |
Lithuanian University of Health Sciences |
2015-06-01 | PHASE2 |
| NCT06936215 | RECRUITING | Diffuse Cutaneous Systemic Sclerosis |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2024-01-01 | PHASE3 |
| NCT06175338 | ACTIVE_NOT_RECRUITING | Rheumatoid Arthritis |
Mabscale, LLC |
2023-06-14 | PHASE1 |
| NCT04310059 | Not yet recruiting | Thalassemia|Folic Acid Deficiency Anemia |
The University of Hong Kong|Queen Mary Hospital Hong Kong |
2024-07-01 | Not Applicable |
| NCT06218030 | Not yet recruiting | Generalized Anxiety Disorder |
Queen''s University |
2024-04 | Phase 4 |
| NCT06314932 | Not yet recruiting | Overweight |
University of Milan|University of Florence|University of Teramo |
2024-04 | Not Applicable |
| NCT04786964 | TERMINATED | Metastatic Non-squamous Non Small Cell Lung Cancer |
Checkpoint Therapeutics, Inc. |
2021-12-08 | PHASE3 |
| NCT05524259 | UNKNOWN | Gestational Diabetes Mellitus; Preeclampsia; Preterm Birth; Polycystic Ovary Syndrome |
Erasmus Medical Center |
2019-06-21 | |
| NCT05312242 | COMPLETED | Adherence, Medication |
Johns Hopkins Bloomberg School of Public Health |
2022-02-10 | |
| NCT04228263 | COMPLETED | Unexplained Recurrent Miscarriage |
Assiut University |
2020-01-01 | |
| NCT04989049 | UNKNOWN | Oral Ulcer |
Dow University of Health Sciences |
2022-09 | EARLY_PHASE1 |
| NCT05097365 | ENROLLING_BY_INVITATION | Overweight and Obesity; Lupus Erythematosus |
University of Sao Paulo |
2022-01-01 | |
| NCT04880499 | COMPLETED | Orthopedic Disorder; Hip Arthropathy; Knee Arthropathy; Anemia; Iron Poor Blood |
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio |
2021-04-21 | |
| NCT04782037 | UNKNOWN | Diarrhoea;Acute |
King Edward Medical University |
2020-10-21 | PHASE4 |
| NCT05943158 | COMPLETED | Pregnancy Related |
Near East University, Turkey |
2021-06-01 | |
| NCT03533712 | COMPLETED | Small for Gestational Age at Delivery; Low Birth Weight; Prematurity; Infant Malnutrition |
University Ghent |
2019-10-30 | PHASE4 |
| NCT03823248 | UNKNOWN | Gastric Precancerous Condition |
Xiyuan Hospital of China Academy of Chinese Medical Sciences |
2019-03-01 | PHASE1; PHASE2 |
| NCT04265534 | TERMINATED | Non-Small Cell Lung Cancer; Non-squamous Non-small-cell Lung Cancer; Non-Squamous Non-Small Cell Neoplasm of Lung; KEAP1 Gene Mutation; NRF2 Gene Mutation; NFE2L2 Gene Mutation |
Calithera Biosciences, Inc |
2020-07-24 | PHASE2 |
| NCT03485404 | TERMINATED | Post Operative Cognitive Dysfunction |
Xijing Hospital |
2019-01-10 | |
| NCT05455073 | COMPLETED | Anemia; Menstrual Hygiene Management; Improved Water, Sanitation and Hygiene (WASH) |
Nutrition International |
2019-07-31 | |
| NCT03994731 | COMPLETED | Gout |
Amgen |
2019-06-13 | PHASE4 |
| NCT03516903 | TERMINATED | Myocardial Infarction, Anterior Wall; Myocardial Remodeling, Ventricular |
University of Sao Paulo |
2018-04-17 | PHASE2; PHASE3 |
| NCT04301336 | COMPLETED | Vaso-occlusive Crisis; Sickle Cell Disease; Sickle Cell Anemia in Children |
Beni-Suef University |
2019-11-01 | PHASE2; PHASE3 |
| NCT04066803 | UNKNOWN | Rheumatoid Arthritis |
Sun Yat-sen University |
2018-08-01 | PHASE4 |
| NCT04645745 | COMPLETED | Polycystic Ovary Syndrome |
AGUNCO Obstetrics and Gynecology Centre |
2019-06-15 | |
| NCT02537392 | COMPLETED | Congenital Heart Disease |
Xi'an Jiaotong University |
2015-09 | |
| NCT02302326 | COMPLETED | Polycystic Ovary Syndrome |
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana |
2013-01 | |
| NCT03193788 | UNKNOWN | Bladder Cancer; Ureter Cancer; Transitional Cell Carcinoma |
Asan Medical Center |
2017-01 | PHASE3 |
| NCT04952051 | COMPLETED | Hypertension |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2014-07-01 | PHASE3 |
| NCT04019899 | COMPLETED | Female Infertility |
Lo.Li.Pharma s.r.l |
2018-05-02 | |
| NCT03950674 | COMPLETED | Non-Small-Cell Lung Carcinoma |
Merck Sharp & Dohme LLC |
2016-02-22 | PHASE3 |
| NCT03384862 | COMPLETED | Arsenic Exposure |
Columbia University |
2018-01-27 | |
| NCT03674333 | UNKNOWN | Dyslipidemias |
Shaheed Zulfiqar Ali Bhutto Medical University |
2018-09-24 | |
| NCT02344888 | UNKNOWN | Infertility; Polycystic Ovarian Syndrome |
Mahmoud Thabet |
2015-02 | PHASE4 |
| NCT03766594 | COMPLETED | Miscarriage, Recurrent |
Ain Shams University |
2018-01-01 | PHASE1 |
| NCT02916121 | UNKNOWN | Schizophrenia |
Taipei Medical University WanFang Hospital |
2016-10 | |
| NCT03332602 | COMPLETED | Iron-deficiency |
Swiss Federal Institute of Technology |
2018-04-04 | |
| NCT03306745 | COMPLETED | Polycystic Ovary Syndrome; Infertility, Female; Micronutrient Deficiency |
Medical University of Vienna |
2017-06-02 | |
| NCT03595163 | UNKNOWN | Sevoflurane; Propofol; Homocysteine; Cochlear Hearing Loss |
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University |
2018-01-01 | |
| NCT03481790 | COMPLETED | Iron Deficiency Anemia of Pregnancy |
Ain Shams Maternity Hospital |
2017-09-01 | PHASE2 |
| NCT01999738 | COMPLETED | Solid Tumors; Non Small Cell Lung Carcinoma |
Endocyte |
2013-10 | PHASE1 |
| NCT03011320 | COMPLETED | Ovary Cancer |
Endocyte |
2017-01-24 | PHASE1 |
| NCT00970866 | COMPLETED | Anemia; Malnutrition; Stunting |
University of California, Davis |
2009-11 | |
| NCT02578680 | COMPLETED | Non-Small-Cell Lung Carcinoma |
Merck Sharp & Dohme LLC |
2016-01-15 | PHASE3 |
| NCT03040219 | UNKNOWN | Primary Malnurtrition |
Ain Shams University |
2017-04-01 | PHASE4 |
| NCT02786823 | COMPLETED | Diabetes Mellitus, Type 2 |
All India Institute of Medical Sciences, Bhubaneswar |
2017-05-01 | PHASE2; PHASE3 |
| NCT02437721 | COMPLETED | Growth and Development |
dsm-firmenich Switzerland AG |
2015-05 | |
| NCT02908581 | COMPLETED | Chronic Arsenic Poisoning |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2016-06 | PHASE2 |
| NCT02644499 | COMPLETED | Rheumatoid Arthritis |
Jawaharlal Institute of Postgraduate Medical Education & Research |
2015-12-31 | PHASE4 |
| NCT02467504 | COMPLETED | Rheumatoid Arthritis |
Peking University People's Hospital |
2015-07-01 | PHASE2 |
| NCT01953536 | WITHDRAWN | Breast Neoplasms |
Endocyte |
2014-04 | PHASE2 |
| NCT01248260 | COMPLETED | Fetal Body Size; Fetal Brain Size |
Hamisu Salihu |
2011-02 | |
| NCT01355159 | COMPLETED | Pregnancy Complications; Preeclampsia |
Ottawa Hospital Research Institute |
2011-04 | PHASE3 |
| NCT01188876 | COMPLETED | Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer |
Massachusetts General Hospital |
2010-08 | PHASE1; PHASE2 |
| NCT02393378 | TERMINATED | Rheumatoid Arthritis |
Takeda |
2015-04-08 | PHASE2 |
| NCT01317849 | WITHDRAWN | Stroke; Transient Ischemic Attack |
Xijing Hospital |
2011-07 | |
| NCT01407432 | COMPLETED | Male Infertility |
Assistance Publique - Hôpitaux de Paris |
2011-11 | PHASE3 |
| NCT02610881 | COMPLETED | Anemia |
Emory University |
2015-12 | |
| NCT02124642 | COMPLETED | Pregnancy |
University of Georgia |
2014-05 | |
| NCT01134341 | COMPLETED | Cutaneous T-cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Primary Cutaneous Anaplastic Large Cell Lymphoma |
Acrotech Biopharma Inc. |
2010-03 | PHASE1 |
| NCT01841658 | COMPLETED | Obesity |
University of Georgia |
2013-04 | |
| NCT02651636 | COMPLETED | Polycystic Ovary Syndrome; Menstrual Pattern; Hyperandrogenism; Metabolic Features |
Catholic University of the Sacred Heart |
2014-06 | |
| NCT02730949 | COMPLETED | Type 1 Diabetes |
Campus Bio-Medico University |
2014-03 | PHASE3 |
| NCT00973609 | COMPLETED | Colorectal Neoplasms |
AIO-Studien-gGmbH |
2009-08 | PHASE3 |
| NCT01873443 | COMPLETED | Rheumatoid Arthritis |
Celltrion |
2013-05 | PHASE1 |
| NCT02079948 | WITHDRAWN | Inflammation; Aging |
University of Florida |
2014-02 | PHASE2 |
| NCT01665378 | COMPLETED | Anemia; Intrauterine Growth Retardation; Preterm Delivery; Iron Deficiency |
Emory University |
2011-10 | |
| NCT01921192 | UNKNOWN | Non Proliferative Diabetic Retinopathy; Proliferative Diabetic Retinopathy |
University of Catania |
2012-09 | PHASE4 |
| NCT01555190 | COMPLETED | Polycystic Ovary Syndrome; Hirsutism; Menstrual Irregularity |
Catholic University of the Sacred Heart |
2012-01 | |
| NCT01956786 | UNKNOWN | Essential Hypertension |
Shenzhen Ausa Pharmed Co.,Ltd |
2013-09 | PHASE2; PHASE3 |
| NCT01850680 | COMPLETED | Rheumatoid Arthritis |
Sanofi |
2013-04 | PHASE1 |
| NCT01210040 | COMPLETED | Malaria |
Liverpool School of Tropical Medicine |
2011-04 | |
| NCT03359057 | COMPLETED | Contraception |
Galeno Desenvolvimento de Pesquisas Clínicas |
2013-02-26 | PHASE3 |
| NCT01856348 | COMPLETED | Physiological Effects of Vitamin D |
University of Zurich |
2013-05 | PHASE1 |
| NCT01047982 | COMPLETED | Gestational Diabetes |
University of Messina |
2010-03 | |
| NCT00923273 | TERMINATED | Carcinoma, Non-Small-Cell Lung |
National Cancer Institute (NCI) |
2008-02-29 | PHASE1; PHASE2 |
| NCT00696514 | UNKNOWN | Osteoporosis; Cognitive Decline |
Wageningen University |
2008-09 | PHASE1 |
| NCT03522428 | COMPLETED | Pregnancy Anemia |
Mirela Zec |
2011-09-15 | PHASE4 |
| NCT01263080 | COMPLETED | Schizophrenia |
Capital Medical University |
2010-11 | PHASE4 |
| NCT01608750 | UNKNOWN | Nonulcer Dyspepsia |
Bezmialem Vakif University |
2012-06 | PHASE4 |
| NCT01828710 | COMPLETED | Asthenozoospermia; Oligospermia |
AGUNCO Obstetrics and Gynecology Centre |
2012-08 | |
| NCT01490944 | UNKNOWN | Anaemia |
Indian Council of Medical Research |
2012-01 | PHASE2 |
| NCT00397917 | COMPLETED | Cleft Lip; Cleft Palate |
University of Iowa |
2006-11 | PHASE3 |
| NCT01116141 | COMPLETED | Rheumatoid Arthritis |
Chelsea Therapeutics |
2010-09 | PHASE2 |
| NCT00554827 | COMPLETED | Cutaneous T-cell Lymphoma |
Acrotech Biopharma Inc. |
2007-08 | PHASE1 |
| NCT00064753 | COMPLETED | Chronic Kidney Disease; Cardiovascular Disease; Death |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2002-05 | PHASE2; PHASE3 |
| NCT00717730 | COMPLETED | Diarrhea; Pneumonia |
Tor A. Strand |
2010-01 | PHASE2 |
| NCT00806819 | COMPLETED | Carcinoma, Non-Small-Cell Lung |
Boehringer Ingelheim |
2008-12 | PHASE3 |
| NCT00481871 | COMPLETED | Relapsed or Refractory Lymphoproliferative Malignancies; Hodgkin's Lymphoma; Peripheral T-cell Lymphoma; B-cell Lymphoma; Waldenstrom's Macroglobulinemia |
Acrotech Biopharma Inc. |
2007-05 | PHASE1; PHASE2 |
| NCT00722553 | COMPLETED | Carcinoma, Transitional Cell; Bladder Cancer; Bladder Neoplasm |
Acrotech Biopharma Inc. |
2008-07 | PHASE2 |
| NCT01010581 | COMPLETED | Rheumatoid Arthritis |
4SC AG |
2009-11 | PHASE2 |
| NCT00730574 | TERMINATED | B12 Deficiency Combined With C677T Mutation on MTHFR Gene |
Moshe Flugelman |
2008-07 | |
| NCT00950989 | COMPLETED | Rheumatoid Arthritis |
Amgen |
2009-12-30 | PHASE2 |
| NCT01194453 | COMPLETED | Non-small Cell Lung Cancer; Efficacy |
Sun Yat-sen University |
2009-11 | PHASE2 |
| NCT00217100 | COMPLETED | Kidney Transplant Recipients |
Mayo Clinic |
2004-10 | PHASE3 |
| NCT00901394 | COMPLETED | Cardiovascular Abnormalities |
Washington University School of Medicine |
2009-03 | |
| NCT03221816 | COMPLETED | Menopause; Dyslipidemias; Homocystinaemia |
Casa de Saúde santa Marcelina |
2008-12 | PHASE4 |
| NCT00578305 | COMPLETED | Rheumatoid Arthritis |
Hoffmann-La Roche |
2007-11 | PHASE3 |
| NCT00781196 | COMPLETED | Gingival Overgrowth |
All India Institute of Medical Sciences |
2008-05 | PHASE3 |
| NCT06516081 | COMPLETED | Anemia |
The Hospital for Sick Children |
2005-09 | |
| NCT00330915 | COMPLETED | Rectal Neoplasms |
Eli Lilly and Company |
2006-06 | PHASE2 |
| NCT01258660 | COMPLETED | Contraception |
Bayer |
2006-12 | PHASE1 |
| NCT00372645 | COMPLETED | Healthy |
Quadram Institute Bioscience |
2005-05 | |
| NCT00116493 | COMPLETED | Anemia |
Johns Hopkins Bloomberg School of Public Health |
2004-04 | PHASE3 |
| NCT00114400 | COMPLETED | Atherosclerosis |
National Institute on Aging (NIA) |
2000-11 | PHASE2; PHASE3 |
| NCT04731948 | COMPLETED | Healthy |
University of Ulster |
2004-10-01 | |
| NCT00680732 | COMPLETED | Malaria; Malaria in Pregnancy |
Institute of Tropical Medicine, Belgium |
2003-06 | PHASE4 |
| NCT00202280 | COMPLETED | First Episode Psychosis |
Melbourne Health |
2004-09 | PHASE2; PHASE3 |
| NCT00611000 | COMPLETED | Colorectal Cancer |
Rockefeller University |
2003-06 | PHASE1 |
| NCT00512850 | COMPLETED | Adenoma of Large Intestine |
Brigham and Women's Hospital |
1996-05 | |
| NCT00822380 | COMPLETED | Anemia |
Universidad Autonoma de Queretaro |
2003-03 | |
| NCT00269542 | COMPLETED | Morbidity; Mortality; Diarrhea; Pneumonia |
Society for Applied Studies |
2002-02 | |
| NCT00003763 | COMPLETED | Ovarian Cancer |
Endocyte |
1997-12-08 | |
| NCT00807807 | COMPLETED | Heart Diseases |
National Heart, Lung, and Blood Institute (NHLBI) |
1996-06 | PHASE3 |
| NCT00111267 | COMPLETED | Cognitive Decline; Cognitive Symptoms |
Wageningen University |
2003-05 | |
| NCT00709332 | COMPLETED | Drug Interactions; Contraception; Pharmacokinetics |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2005-01 | PHASE1 |
| NCT00570856 | TERMINATED | Kidney Transplantation |
Shahid Beheshti University of Medical Sciences |
2005-06 | PHASE4 |
| NCT00126347 | COMPLETED | Healthy; Cardiovascular Diseases |
Wageningen Centre for Food Sciences |
2002-08 | |
| NCT01560065 | COMPLETED | Sperm Quality; Oligoasthenospermia |
AGUNCO Obstetrics and Gynecology Centre |
PHASE4 | |
| NCT00709189 | COMPLETED | Female Contraception; Contraception; Therapeutic Equivalency; Pharmacokinetics |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2005-05 | PHASE1 |
| NCT00170404 | COMPLETED | Mycobacterium Tuberculosis |
National Institute of Allergy and Infectious Diseases (NIAID) |
2000-06 | PHASE3 |
| NCT00314990 | COMPLETED | Deep-Vein Thrombosis; Pulmonary Embolism |
Radboud University Medical Center |
1996-01 | |
| NCT00470522 | COMPLETED | Systemic Lupus Erythematosus |
University Health Network, Toronto |
1995-06 | PHASE3 |
| NCT00709982 | COMPLETED | Drug Interactions; Healthy; Pharmacokinetics |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2005-05 | PHASE1 |
| NCT00491907 | TERMINATED | Heart Failure |
University of Zurich |
2004-10 | PHASE4 |
| NCT00709267 | COMPLETED | Healthy; Pharmacokinetics |
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
2004-10 | PHASE1 |
| NCT00033722 | UNKNOWN | Lung Cancer |
Tularik |
2002-02 | PHASE2 |
| NCT00120822 | COMPLETED | Malaria |
London School of Hygiene and Tropical Medicine |
2002-07 | PHASE3 |
| NCT00520247 | COMPLETED | Plasma Total Homocysteine Level; Blood Pressure |
Anhui Medical University |
2005-09 | PHASE2 |
| NCT01511835 | UNKNOWN | Gestational Diabetes |
AGUNCO Obstetrics and Gynecology Centre |
PHASE4 |
(data from https://clinicaltrials.gov, updated on 2026-01-14)
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).